Ev3 Atherectomy Biz Stabilizing After Sales Force Improvements, Firm Says
This article was originally published in The Gray Sheet
Executive SummaryEv3 believes a sales force restructuring initiated earlier this year is bearing fruit for its struggling atherectomy business
You may also be interested in...
The head of the European Medicines Agency is nearing the end of his tenure. We consider Guido Rasi’s achievements over the past 10 years as well as the controversies that have arisen under his leadership – and report that sailing is likely to figure in his plans for life after the agency.